Association between PER3 length polymorphism and onco-hematological diseases and its influence on patients functionality

• Autores: Cerliani, María Belén; Gili, Juan Antonio; Pavicic, Walter Hernán; Klein, Graciela; Saba, Silvia; Richard, Silvina Mariel
• Año de publicación: 2015
• Idioma: inglés
• Tipo de recurso: artículo
• Materia: Biología Celular, Microbiología; PER3; polimorfismo; Neoplasias Hematológicas; ritmos circadianos
• Institución: Comisión de Investigaciones Científicas de la Provincia de Buenos Aires

Circadian clock gene PER3 and its length polymorphism may have a role in oncogenesis as clock genes act as key regulators of cell cycle and DNA repair pathways. The polymorphism may affect the condition of patients who show disrupted circadian rhythm due to tumor development. The aim was to assess the association between PER3 polymorphism and onco-hematological diseases, and analyze whether this variant has an impact on patient’s functionality. We conducted a case-control study on 125 patients with onco-hematological diseases and 310 control patients. PER3 allelic variants were detected by using polymerase chain reaction. Sociodemographic data and information on patient’s habits and functionality were obtained through questionnaire. Genotypes 4/5 + 5/5 showed an odd ratio (OR) = 1.39, with no statistical significance. However, those genotypes were associated with a two-fold increase in the risk of acute/chronic lymphoblastic/myeloblastic leukemia, taken all together. The occurrence of “changes in humor during last two months” was significantly associated with onco-hematological diseases. “Fatigue on awakening” and “self-reported snore” were associated with cases carrying the 4/5 or 5/5 genotypes. The results suggested that PER3 polymorphism may have a role in the risk of leukemia, and might be a possible marker for individual differences in susceptibility to sleep disruption. This work provides insights for the identification of individuals at high risk of cancer, and those who are more susceptible to circadian disruption, which may decrease the physiological defenses against the tumor.